14.20
Avadel Pharmaceuticals Plc stock is traded at $14.20, with a volume of 1.00M.
It is up +1.43% in the last 24 hours and down -7.79% over the past month.
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
See More
Previous Close:
$14.00
Open:
$13.98
24h Volume:
1.00M
Relative Volume:
0.77
Market Cap:
$1.38B
Revenue:
$221.08M
Net Income/Loss:
$-2.92M
P/E Ratio:
284.00
EPS:
0.05
Net Cash Flow:
$5.89M
1W Performance:
-2.27%
1M Performance:
-7.79%
6M Performance:
+84.90%
1Y Performance:
+8.23%
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Name
Avadel Pharmaceuticals Plc
Sector
Phone
636-449-1830
Address
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
Compare AVDL with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
AVDL
Avadel Pharmaceuticals Plc
|
14.20 | 1.36B | 221.08M | -2.92M | 5.89M | 0.05 |
![]()
ZTS
Zoetis Inc
|
142.26 | 62.54B | 9.39B | 2.62B | 2.22B | 5.8121 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 43.30B | 29.96B | 957.25M | 4.77B | 0.2956 |
![]()
HLN
Haleon Plc Adr
|
9.08 | 40.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.02 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
![]()
UTHR
United Therapeutics Corp
|
440.06 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-03-25 | Initiated | Wells Fargo | Equal Weight |
Jul-18-25 | Resumed | H.C. Wainwright | Buy |
Feb-11-25 | Initiated | Deutsche Bank | Buy |
Jun-12-24 | Initiated | Rodman & Renshaw | Buy |
Mar-05-24 | Reiterated | H.C. Wainwright | Buy |
Mar-05-24 | Reiterated | Needham | Buy |
Mar-05-24 | Reiterated | Oppenheimer | Outperform |
Feb-06-24 | Initiated | UBS | Buy |
Nov-30-22 | Upgrade | Jefferies | Hold → Buy |
Aug-10-22 | Downgrade | Jefferies | Buy → Hold |
Jul-28-22 | Resumed | Craig Hallum | Buy |
May-26-22 | Downgrade | Stifel | Buy → Hold |
Sep-23-21 | Initiated | Needham | Buy |
Jul-31-20 | Initiated | Oppenheimer | Outperform |
Jul-21-20 | Initiated | SVB Leerink | Outperform |
Jun-30-20 | Initiated | H.C. Wainwright | Buy |
Apr-03-20 | Initiated | Jefferies | Buy |
Mar-12-20 | Initiated | Stifel | Buy |
Feb-26-20 | Initiated | Piper Sandler | Overweight |
Jan-30-20 | Initiated | Craig Hallum | Buy |
Jun-14-19 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
Feb-08-19 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
View All
Avadel Pharmaceuticals Plc Stock (AVDL) Latest News
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Why Avadel Pharmaceuticals plc stock is a value investor pickQuarterly Earnings Report & Safe Entry Point Alerts - newser.com
What institutional flow reveals about Avadel Pharmaceuticals plcMarket Sentiment Summary & Reliable Price Action Trade Plans - newser.com
Strategies to average down on Avadel Pharmaceuticals plc2025 Retail Activity & Daily Profit Focused Stock Screening - newser.com
Is Avadel Pharmaceuticals plc stock positioned well for digital economyOil Prices & Free Technical Confirmation Trade Alerts - newser.com
Long term hold vs stop loss in Avadel Pharmaceuticals plcMarket Weekly Review & Target Return Focused Picks - newser.com
How risky is Avadel Pharmaceuticals plc stock now2025 Price Action Summary & Low Drawdown Trading Strategies - newser.com
Can Avadel Pharmaceuticals plc stock maintain growth trajectoryEarnings Growth Report & Verified Technical Signals - newser.com
Is Avadel Pharmaceuticals plc (AWK) stock a contrarian opportunityTrade Entry Summary & Verified Short-Term Trading Plans - newser.com
Why Avadel Pharmaceuticals plc (AWK) stock trades below fair valueJuly 2025 Decliners & Fast Exit Strategy with Risk Control - newser.com
How to build a custom watchlist for Avadel Pharmaceuticals plcMarket Risk Analysis & Growth Focused Stock Reports - newser.com
Can Avadel Pharmaceuticals plc (AWK) stock hold up in economic slowdownIPO Watch & Entry Point Strategy Guides - newser.com
Is Avadel Pharmaceuticals plc stock a defensive play in 2025July 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com
Should you hold or exit Avadel Pharmaceuticals plc nowIndex Update & AI Driven Stock Reports - newser.com
Avadel Pharmaceuticals (NASDAQ:AVDL) Cut to “Hold” at Zacks Research - Defense World
Avadel Pharmaceuticals (NASDAQ:AVDL) Downgraded to Hold Rating by Zacks Research - MarketBeat
Q3 Earnings Forecast for AVDL Issued By Leerink Partnrs - MarketBeat
Using economic indicators to assess Avadel Pharmaceuticals plc potentialEarnings Miss & Low Risk High Reward Ideas - newser.com
Avadel Pharmaceuticals (NASDAQ:AVDL) Given Sell (E+) Rating at Weiss Ratings - MarketBeat
What drives Avadel Pharmaceuticals plc stock priceTrading Psychology Tips & Exceptional Profit Ideas - earlytimes.in
Avadel Pharmaceuticals plc stock trend forecastJuly 2025 Highlights & Weekly Breakout Opportunity Watchlist - newser.com
Using portfolio simulators with Avadel Pharmaceuticals plc includedPortfolio Update Summary & Real-Time Chart Pattern Alerts - newser.com
Volatility clustering patterns for Avadel Pharmaceuticals plc2025 Major Catalysts & Capital Protection Trading Alerts - newser.com
Analysts Expect Avadel Pharmaceuticals plc (NASDAQ:AVDL) To Breakeven Soon - Yahoo Finance
Custom strategy builders for tracking Avadel Pharmaceuticals plcDollar Strength & Safe Capital Growth Trade Ideas - newser.com
How strong is Avadel Pharmaceuticals plc (AWK) stock earnings growthMarket Performance Report & Community Shared Stock Ideas - newser.com
Can Avadel Pharmaceuticals plc stock withstand economic slowdownMarket Movement Recap & Step-by-Step Trade Execution Guides - newser.com
Is Avadel Pharmaceuticals plc stock attractive after correctionRisk Management & Daily Entry Point Alerts - newser.com
Is Avadel Pharmaceuticals plc (AWK) stock good for long term investingWeekly Trade Recap & Precise Buy Zone Identification - newser.com
Is Avadel Pharmaceuticals plc a good long term investmentCovered Call Writing & Make Confident Moves With Forecasting Models - earlytimes.in
Will Avadel Pharmaceuticals plc stock maintain dividend yieldQuarterly Growth Report & AI Driven Stock Reports - newser.com
Avadel: Mispriced Leader In Once-Nightly Sleep Therapies - Seeking Alpha
What analysts say about Avadel Pharmaceuticals plc stockBollinger Bands Signals & Free Stock Trading Signal Access - earlytimes.in
Avadel Pharmaceuticals gains as holder pushes for sale process - MSN
Avadel Pharmaceuticals Plc Stock (AVDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Avadel Pharmaceuticals Plc Stock (AVDL) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Thornton Peter J. | Director |
Jan 13 '25 |
Buy |
8.04 |
10,000 |
80,450 |
104,055 |
Ende Eric J | Director |
Jan 13 '25 |
Buy |
7.84 |
30,000 |
235,218 |
208,900 |
MCHUGH THOMAS S | Chief Financial Officer |
Dec 13 '24 |
Buy |
10.44 |
2,300 |
24,019 |
87,800 |
MCHUGH THOMAS S | Chief Financial Officer |
Dec 11 '24 |
Buy |
10.49 |
5,000 |
52,432 |
85,500 |
Divis Gregory J | Chief Executive Officer |
Dec 06 '24 |
Buy |
9.98 |
9,598 |
95,759 |
9,598 |
Divis Gregory J | Chief Executive Officer |
Dec 09 '24 |
Buy |
9.82 |
402 |
3,948 |
10,000 |
Glass Geoffrey Michael | Director |
Dec 10 '24 |
Buy |
9.84 |
20,279 |
199,641 |
75,904 |
Palczuk Linda | Director |
Dec 06 '24 |
Buy |
10.19 |
3,000 |
30,568 |
66,400 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):